BioCentury | Sep 21, 2009
Financial News

Aastrom completes private placement

...Type: Private placement Raised: $3.3 million Shares: 8.6 million Shares after offering: 170.6 million Investor: Fusion Capital...
...Note: Shares were purchased at market prices under a June common stock purchase program with Fusion Capital...
BioCentury | Apr 14, 2006
Financial News

Hemispherx gets $50M facility

...HEB entered into a financing agreement under which Fusion Capital will provide HEB with up to $50...
BioCentury | Oct 25, 2005
Financial News

GLGS, Fusion stock purchase agreement

Fusion Capital agreed to purchase up to $20 million in GlycoGenesys (GLGS) stock over a 25-month period at GLGS's discretion. The company's GCS-100LE, a low ethanol formulation of a carbohydrate lectin inhibitor, is in Phase...
BioCentury | Jan 13, 2005
Financial News

Aastrom raises $12 million

...company ASTM raised $12 million through the sale of 4.8 million shares at $2.50 to Fusion Capital...
Items per page:
1 - 4 of 4
BioCentury | Sep 21, 2009
Financial News

Aastrom completes private placement

...Type: Private placement Raised: $3.3 million Shares: 8.6 million Shares after offering: 170.6 million Investor: Fusion Capital...
...Note: Shares were purchased at market prices under a June common stock purchase program with Fusion Capital...
BioCentury | Apr 14, 2006
Financial News

Hemispherx gets $50M facility

...HEB entered into a financing agreement under which Fusion Capital will provide HEB with up to $50...
BioCentury | Oct 25, 2005
Financial News

GLGS, Fusion stock purchase agreement

Fusion Capital agreed to purchase up to $20 million in GlycoGenesys (GLGS) stock over a 25-month period at GLGS's discretion. The company's GCS-100LE, a low ethanol formulation of a carbohydrate lectin inhibitor, is in Phase...
BioCentury | Jan 13, 2005
Financial News

Aastrom raises $12 million

...company ASTM raised $12 million through the sale of 4.8 million shares at $2.50 to Fusion Capital...
Items per page:
1 - 4 of 4